ClinVar Miner

Submissions for variant NM_153717.3(EVC):c.919T>C (p.Ser307Pro)

gnomAD frequency: 0.00001  dbSNP: rs121908426
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München RCV000005672 SCV000680219 pathogenic Ellis-van Creveld syndrome 2017-12-09 criteria provided, single submitter clinical testing
Counsyl RCV000005672 SCV000789079 likely pathogenic Ellis-van Creveld syndrome 2017-01-05 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001383029 SCV001582037 pathogenic Ellis-van Creveld syndrome; Curry-Hall syndrome 2024-01-16 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 307 of the EVC protein (p.Ser307Pro). This variant is present in population databases (rs121908426, gnomAD 0.01%). This missense change has been observed in individual(s) with EVC-related conditions (PMID: 10700184, 29321360). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5343). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EVC protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.
Laboratory of Medical Genetics, National & Kapodistrian University of Athens RCV000005672 SCV005051759 pathogenic Ellis-van Creveld syndrome 2024-02-01 criteria provided, single submitter curation
OMIM RCV000005672 SCV000025853 pathogenic Ellis-van Creveld syndrome 2013-02-01 no assertion criteria provided literature only
Natera, Inc. RCV000005672 SCV002083021 pathogenic Ellis-van Creveld syndrome 2021-08-12 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.